Frontmatter

Home Frontmatter

Article Publicly Available

Published/Copyright: June 2, 2020

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

"Frontmatter" Reviews in the Neurosciences, vol. 31, no. 4, 2020, pp. i-iii. https://doi.org/10.1515/revneuro-2020-frontmatter4

(2020). Frontmatter. Reviews in the Neurosciences, 31(4), i-iii. https://doi.org/10.1515/revneuro-2020-frontmatter4

(2020) Frontmatter. Reviews in the Neurosciences, Vol. 31 (Issue 4), pp. i-iii. https://doi.org/10.1515/revneuro-2020-frontmatter4

"Frontmatter" Reviews in the Neurosciences 31, no. 4 (2020): i-iii. https://doi.org/10.1515/revneuro-2020-frontmatter4

Frontmatter. Reviews in the Neurosciences. 2020;31(4): i-iii. https://doi.org/10.1515/revneuro-2020-frontmatter4

Copied to clipboard

Published Online: 2020-06-02

Published in Print: 2020-05-26

Articles in the same Issue

Frontmatter
A complete overview of REEP1: old and new insights on its role in hereditary spastic paraplegia and neurodegeneration
Brain energetics, mitochondria, and traumatic brain injury
Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues
Gut dysbiosis and serotonin: intestinal 5-HT as a ubiquitous membrane permeability regulator in host tissues, organs, and the brain
Assessment of the efficacy of passive cellular immunotherapy for glioma patients
Pridopidine in the treatment of Huntington’s disease
The involvement of the central nervous system in patients with COVID-19

Search journal Search the content of this journal

Frontmatter
A complete overview of REEP1: old and new insights on its role in hereditary spastic paraplegia and neurodegeneration
Brain energetics, mitochondria, and traumatic brain injury
Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues
Gut dysbiosis and serotonin: intestinal 5-HT as a ubiquitous membrane permeability regulator in host tissues, organs, and the brain
Assessment of the efficacy of passive cellular immunotherapy for glioma patients
Pridopidine in the treatment of Huntington’s disease
The involvement of the central nervous system in patients with COVID-19